8 completed, 1 recruiting, 1 terminated. 6 Phase 3, 3 Phase 4, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 4, Recruiting 1, Terminated 1 |
| Phase 4 | 3 | Completed 3 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Ferrous sulfate tablets: new trials by email Literature Review of Ferrous sulfate tablets trials Research Report on Ferrous sulfate tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient Ferumoxytol, Saline, Ferrous sulfate tablets - Iron Deficiency Anemia | Phase 3 | Recruiting | Auerbach Hematology Oncology Associates P C | 104 | 2020-02-27 | 2025-10-03 |
| Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass Injectafer, Ferrous Sulfate tablets - Iron Deficiency Anemia Secondary to IBD or Gastric Bypass | Phase 4 | Completed | American Regent, Inc. | 198 | 2014-01-01 | 2020-09-17 |
| Oral Iron Supplementation in Pulmonary Hypertension iron supplement - Pulmonary Arterial Hypertension | Not applicable | Completed | The Cleveland Clinic | 6 | 2012-01-01 | 2014-08-12 |
| Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA) Ferric Carboxymaltose (FCM), Ferrous Sulfate Tablets, IV Iron (standard of care) - Iron Deficiency Anemia | Phase 3 | Completed | American Regent, Inc. | 997 | 2009-09-01 | 2018-02-20 |
| Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia Ferric carboxymaltose, Ferrous sulfate tablets - Anemia, Iron-Deficiency, Puerperal Disorders | Phase 2 / Phase 3 | Terminated | Norwegian University of Science and Technology | 30 | 2009-06-01 | 2012-02-17 |
| Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients Ferric Carboxymaltose (FCM), Ferrous Sulfate tablets - Postpartum Anemia | Phase 3 | Completed | American Regent, Inc. | 291 | 2006-05-01 | 2018-02-20 |
| VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Ferrous Sulfate tablets, Ferric Carboxymaltose (FCM) - Anemia | Phase 3 | Completed | American Regent, Inc. | 255 | 2005-05-01 | 2018-02-20 |
| Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding Ferric Carboxymaltose (FCM), Ferrous Sulfate tablets - Anemia | Phase 3 | Completed | American Regent, Inc. | 456 | 2005-05-01 | 2018-02-20 |
| Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Sodium Ferric Gluconate Complex in Sucrose Injection, Ferrous sulfate tablets - Anemia, Iron-Deficiency, Kidney Failure, Chronic | Phase 4 | Completed | Watson Pharmaceuticals | 89 | 2003-04-01 | 2012-03-29 |
| Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents Sodium Ferric Gluconate complex in sucrose, Ferrous sulfate tablets - Anemia, Iron-Deficiency, Kidney Failure, Chronic | Phase 4 | Completed | Watson Pharmaceuticals | 52 | 2003-04-01 | 2012-03-29 |
Anemia (5) · Anemia, Iron-Deficiency (5) · Iron Deficiencies (3) · Renal Insufficiency, Chronic (3) · Bronchiolitis Obliterans Syndrome (2) · Kidney Failure, Chronic (2) · Renal Insufficiency (2) · Depression, Postpartum (1) · Hypertension, Pulmonary (1) · Menorrhagia (1) · Puerperal Disorders (1) · Pulmonary Arterial Hypertension (1)
American Regent, Inc. (5) · Watson Pharmaceuticals (2) · Auerbach Hematology Oncology Associates P C (1) · Norwegian University of Science and Technology (1) · The Cleveland Clinic (1)
United States (8) · Puerto Rico (2) · Norway (1)
Adel R Rizkala, PharmD, MS (1) · Bjorn Backe, MD PhD (1) · Mark A Falone, MD (1) · Naomi Dahl, Pharm.D. (1) · Samar Farha, MD (1)
PMID 17035697, PMID 17666600, PMID 18567277, PMID 18752459, PMID 18928998, PMID 19682342, PMID 20929915
2008 (1)